Future Monetary Costs of Dementia in the United States under Alternative Dementia Prevalence Scenarios
- PMID: 25926904
- PMCID: PMC4410878
- DOI: 10.1007/s12062-015-9112-4
Future Monetary Costs of Dementia in the United States under Alternative Dementia Prevalence Scenarios
Abstract
Population aging will likely lead to increases is health care spending and the ability of governments to support entitlement programs such as Medicare and Medicaid. Dementia is a chronic condition that is especially pertinent because of its strong association with old age and because care for dementia is labor intensive and expensive. Indeed, prior research has found that if current dementia prevalence rates persist population aging will generate very large increases in health care spending for dementia. In this study we considered two alternative assumptions or scenarios about future prevalence. The first adjusts the prevalence projections using recent research that suggests dementia prevalence may be declining. The second uses growth hypertension, obesity and diabetes, and the relationship between dementia and these conditions to adjust future prevalence rates. We find under the first scenario that if the rates of decline in age-specific dementia rates persist, future costs will be much less than previous estimates, about 40% lower. Under the second scenario, the growth in those conditions makes only small differences in costs.
Keywords: Forecasts of health care costs; dementia.
Similar articles
-
Global and regional spending on dementia care from 2000-2019 and expected future health spending scenarios from 2020-2050: An economic modelling exercise.EClinicalMedicine. 2022 Mar 13;45:101337. doi: 10.1016/j.eclinm.2022.101337. eCollection 2022 Mar. EClinicalMedicine. 2022. PMID: 35299657 Free PMC article.
-
Disability forecasts and future Medicare costs.Front Health Policy Res. 2004;7:75-94. doi: 10.2202/1558-9544.1052. Front Health Policy Res. 2004. PMID: 15612336 Free PMC article.
-
The Effect of Obesity and Chronic Conditions on Medicare Spending, 1987-2011.Pharmacoeconomics. 2015 Jul;33(7):691-7. doi: 10.1007/s40273-015-0284-9. Pharmacoeconomics. 2015. PMID: 25943686 Review.
-
The aging of America. Impact on health care costs.JAMA. 1990 May 2;263(17):2335-40. JAMA. 1990. PMID: 2109105
-
Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.Am J Manag Care. 2001 Aug;7(8):809-18. Am J Manag Care. 2001. PMID: 11519239 Review.
Cited by
-
Dementia-focused programs in older adult centers and health care use among individuals with dementia.Health Aff Sch. 2024 Aug 30;2(9):qxae108. doi: 10.1093/haschl/qxae108. eCollection 2024 Sep. Health Aff Sch. 2024. PMID: 39310921 Free PMC article.
-
The Impact of Changes in Population Health and Mortality on Future Prevalence of Alzheimer's Disease and Other Dementias in the United States.J Gerontol B Psychol Sci Soc Sci. 2018 Apr 16;73(suppl_1):S38-S47. doi: 10.1093/geronb/gbx147. J Gerontol B Psychol Sci Soc Sci. 2018. PMID: 29669100 Free PMC article.
-
Protective effects of sulforaphane in experimental vascular cognitive impairment: Contribution of the Nrf2 pathway.J Cereb Blood Flow Metab. 2019 Feb;39(2):352-366. doi: 10.1177/0271678X18764083. Epub 2018 Mar 13. J Cereb Blood Flow Metab. 2019. PMID: 29533123 Free PMC article.
-
Amelioration of oxidative stress and neuroinflammation in lipopolysaccharide-induced memory impairment using Rosmarinic acid in mice.Metab Brain Dis. 2021 Feb;36(2):299-313. doi: 10.1007/s11011-020-00629-9. Epub 2020 Oct 17. Metab Brain Dis. 2021. PMID: 33068223
-
Global and regional spending on dementia care from 2000-2019 and expected future health spending scenarios from 2020-2050: An economic modelling exercise.EClinicalMedicine. 2022 Mar 13;45:101337. doi: 10.1016/j.eclinm.2022.101337. eCollection 2022 Mar. EClinicalMedicine. 2022. PMID: 35299657 Free PMC article.
References
-
- Chan KY, Wang W, Wu JJ, Liu L, Theodoratou E, Car J, et al. Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990–2010: a systematic review and analysis. Lancet. 2013;381(9882):2016–2023. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources